- Home
- LTRX vs SRZN Comparison
LTRX vs SRZN Comparison
Compare LTRX & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTRX | SRZN |
|---|---|---|
| Founded | 1989 | 2015 |
| Country | United States | United States |
| Employees | N/A | 59 |
| Industry | Computer Communications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 328.9M | 276.3M |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LTRX | SRZN |
|---|---|---|
| Price | $4.40 | $31.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | $10.50 | ★ $63.50 |
| AVG Volume (30 Days) | ★ 647.2K | 272.4K |
| Earning Date | 11-09-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.52 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $120,899,000.00 | $3,477,000.00 |
| Revenue This Year | $13.33 | $187.60 |
| Revenue Next Year | $14.28 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.36 | $12.52 |
| 52 Week High | $8.75 | $37.83 |
Technical Indicators
Market Signals| Indicator | LTRX | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 30.04 | 59.12 |
| Support Level | N/A | $22.61 |
| Resistance Level | $6.88 | $33.96 |
| Average True Range (ATR) | 0.42 | 2.22 |
| MACD | -0.14 | 0.14 |
| Stochastic Oscillator | 4.34 | 65.22 |
Price Performance
Historical ComparisonAbout LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The company operates in a single operating segment: the development, marketing, and sale of industrial and enterprise IoT products and services. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic regions: the Americas; EMEA; and APJ. The Americas contribute the vast majority of total revenue.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).